Increasing evidence demonstrates that PI3K/Akt and MAPK signaling pathways account for an increase in proliferation and metastasis of cancer cells, and their inhibition is important in cancer therapy [140,141,142,143]. This evidence concerns the gene AKT1 and cancer.